Randomized, Open Label, Phase 3 Trial of Neoadjuvant Nivolumab and Ipilimumab Plus Chemotherapy Versus Platinum Doublet Chemotherapy Alone in Early Stage NSCLC
- 26/08/2018
- 3360
- Comments Off on Checkmate 816 / CA209-816
Randomized, Open Label, Phase 3 Trial of Neoadjuvant Nivolumab and Ipilimumab Plus Chemotherapy Versus Platinum Doublet Chemotherapy Alone in Early Stage NSCLC
Our website is under development. We're sorry for any inconvenience that might appear.Notre site web est en cours de développement. Nous sommes désolés pour tout inconvénient qui pourrait survenir.
Please select an account type above.